Cefa-Drops en es it fr

Cefa-Drops Brand names, Cefa-Drops Analogs

Cefa-Drops Brand Names Mixture

  • None

Cefa-Drops Chemical_Formula


Cefa-Drops RX_link


Cefa-Drops fda sheet

Cefa-Drops msds (material safety sheet)

Cefa-Drops Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Cefa-Drops Molecular Weight

363.389 g/mol

Cefa-Drops Melting Point


Cefa-Drops H2O Solubility

1110 mg/L

Cefa-Drops State


Cefa-Drops LogP


Cefa-Drops Dosage Forms

Capsule; Tablet; Oral liquid

Cefa-Drops Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Cefa-Drops Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Cefa-Drops Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Cefa-Drops side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Cefa-Drops Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Cefa-Drops Organisms Affected

Enteric bacteria and other eubacteria